All of our ingredients are transgenic and cruelty free
What are the risks of grey-market retatrutide pens
Still, absence of evidence is not evidence of absence: we lack long-term, high-quality studies
Clinical trials show tirzepatide achieved up to 22% weight loss, while semaglutide achieved approximately 15% in comparable studies
In a statement to Yahoo, Eli Lilly, maker of Mounjaro and Zepbound, noted that patient safety is the company's top priority and that it actively monitors and evaluates safety information for all its medicines, encouraging anyone experiencing side effects to speak with their health care provider or contact the Lilly Answers Center at 1-800-LillyRx (1-800-545-5979)
UnitedHealthcare covers Mounjaro only for Type 2 diabetes, its FDA-approved indication